Chemoinformaics analysis of 1-hydroxy-2-methyl-9,10-an-thraquinone
| Molecular Weight | 238.242 | nRot | 0 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 18 |
| Exact Molecular Weight | 238.063 | nRing | 3 |
| Solubility: LogS | -4.581 | nHRing | 0 |
| Solubility: LogP | 3.935 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 34.1239 |
| nHD | 1 | BPOL | 11.7681 |
| QED | 0.654 |
| Synth | 1.923 |
| Natural Product Likeliness | 0.796 |
| NR-PPAR-gamma | 0.946 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.146 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.787 |
| MDCK | 0.0000165 |
| BBB | 0.15 |
| PPB | 0.99932 |
| VDSS | 0.5 |
| FU | 0.00796282 |
| CYP1A2-inh | 0.945 |
| CYP1A2-sub | 0.396 |
| CYP2c19-inh | 0.499 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.582 |
| CYP2c9-sub | 0.386 |
| CYP2d6-inh | 0.229 |
| CYP2d6-sub | 0.242 |
| CYP3a4-inh | 0.432 |
| CYP3a4-sub | 0.176 |
| CL | 3.82 |
| T12 | 0.068 |
| hERG | 0.015 |
| Ames | 0.875 |
| ROA | 0.382 |
| SkinSen | 0.152 |
| Carcinogencity | 0.946 |
| EI | 0.975 |
| Respiratory | 0.065 |
| NR-Aromatase | 0.642 |
| Antiviral | Yes |
| Prediction | 0.697075 |